717
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

CD44 ligation with A3D8 antibody induces apoptosis in acute myeloid leukemia cells through binding to CD44s and clustering lipid rafts

, , , &
Pages 1276-1283 | Received 17 Apr 2012, Accepted 08 Aug 2012, Published online: 16 Aug 2012

References

  • Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hematological neoplasias. Ann Hematol 2011; 90:493 - 508; http://dx.doi.org/10.1007/s00277-011-1161-z; PMID: 21258793
  • Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992; 89:12160 - 4; http://dx.doi.org/10.1073/pnas.89.24.12160; PMID: 1465456
  • Ghaffari S, Dougherty GJ, Eaves AC, Eaves CJ. Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 1996; 10:1773 - 81; PMID: 8892681
  • Bendall LJ, Bradstock KF, Gottlieb DJ. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia 2000; 14:1239 - 46; http://dx.doi.org/10.1038/sj.leu.2401830; PMID: 10914548
  • Legras S, Günthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans HC, et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91:3401 - 13; PMID: 9558399
  • Yokota A, Ishii G, Sugaya Y, Nishimura M, Saito Y, Harigaya K. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia. Hematol Oncol 1998; 16:131 - 41; http://dx.doi.org/10.1002/(SICI)1099-1069(199812)16:4<131::AID-HON631>3.0.CO;2-K; PMID: 10414233
  • Mielgo A, Brondani V, Landmann L, Glaser-Ruhm A, Erb P, Stupack D, et al. The CD44 standard/ezrin complex regulates Fas-mediated apoptosis in Jurkat cells. Apoptosis 2007; 12:2051 - 61; http://dx.doi.org/10.1007/s10495-007-0115-3; PMID: 17726647
  • Mielgo A, van Driel M, Bloem A, Landmann L, Günthert U. A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ 2006; 13:465 - 77; http://dx.doi.org/10.1038/sj.cdd.4401763; PMID: 16167069
  • Artus C, Maquarre E, Moubarak RS, Delettre C, Jasmin C, Susin SA, et al. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene 2006; 25:5741 - 51; http://dx.doi.org/10.1038/sj.onc.1209581; PMID: 16636662
  • Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, et al. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk Lymphoma 2004; 45:1501 - 10; http://dx.doi.org/10.1080/1042819042000206687; PMID: 15370200
  • Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jasmin C, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002; 99:290 - 9; http://dx.doi.org/10.1182/blood.V99.1.290; PMID: 11756184
  • Bourcier S, Sansonetti A, Durand L, Chomienne C, Robert-Lézénés J, Smadja-Joffe F. CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-alpha and IL-6 required for differentiation of THP-1 monoblastic leukemia cells. Leukemia 2010; 24:1372 - 5; http://dx.doi.org/10.1038/leu.2010.100; PMID: 20508620
  • Charrad RS, Li Y, Delpech B, Balitrand N, Clay D, Jasmin C, et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999; 5:669 - 76; http://dx.doi.org/10.1038/9518; PMID: 10371506
  • Maquarre E, Artus C, Gadhoum Z, Jasmin C, Smadja-Joffe F, Robert-Lézénès J. CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells. Leukemia 2005; 19:2296 - 303; http://dx.doi.org/10.1038/sj.leu.2403944; PMID: 16208414
  • Onoda M, Nakaseko C, Yokota A, Saito Y. Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line. Hematology 2009; 14:213 - 9; http://dx.doi.org/10.1179/102453309X426236; PMID: 19635184
  • Kruidering M, Evan GI. Caspase-8 in apoptosis: the beginning of “the end”?. IUBMB Life 2000; 50:85 - 90; PMID: 11185963
  • Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008; 1785:182 - 206
  • Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS One 2009; 4:e5044; http://dx.doi.org/10.1371/journal.pone.0005044; PMID: 19352436
  • Gajate C, Mollinedo F. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy. Recent Pat Anticancer Drug Discov 2011; 6:274 - 83; http://dx.doi.org/10.2174/157489211796957766; PMID: 21762074
  • Peterson LF, Wang Y, Lo MC, Yan M, Kanbe E, Zhang DE. The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation. Leukemia 2007; 21:2010 - 9; http://dx.doi.org/10.1038/sj.leu.2404849; PMID: 17657222
  • Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, et al. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res 2010; 16:2046 - 54; http://dx.doi.org/10.1158/1078-0432.CCR-09-2456; PMID: 20233887
  • Schimmer AD. Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia. Curr Treat Options Oncol 2007; 8:277 - 86; http://dx.doi.org/10.1007/s11864-007-0037-x; PMID: 18004514
  • Del Poeta G, Bruno A, Del Principe MI, Venditti A, Maurillo L, Buccisano F, et al. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia. Curr Cancer Drug Targets 2008; 8:207 - 22; http://dx.doi.org/10.2174/156800908784293640; PMID: 18473734
  • Roboz GJ, Guzman M. Acute myeloid leukemia stem cells: seek and destroy. Expert Rev Hematol 2009; 2:663 - 72; http://dx.doi.org/10.1586/ehm.09.53; PMID: 21082958
  • Misaghian N, Ligresti G, Steelman LS, Bertrand FE, Bäsecke J, Libra M, et al. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 2009; 23:25 - 42; http://dx.doi.org/10.1038/leu.2008.246; PMID: 18800146
  • Herishanu Y, Gibellini F, Njuguna N, Hazan-Halevy I, Farooqui M, Bern S, et al. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. Leuk Lymphoma 2011; 52:1758 - 69; http://dx.doi.org/10.3109/10428194.2011.569962; PMID: 21649540
  • Lakshman M, Subramaniam V, Jothy S. CD44 negatively regulates apoptosis in murine colonic epithelium via the mitochondrial pathway. Exp Mol Pathol 2004; 76:196 - 204; http://dx.doi.org/10.1016/j.yexmp.2003.12.009; PMID: 15126101
  • Bourguignon LY, Xia W, Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 2009; 284:2657 - 71; http://dx.doi.org/10.1074/jbc.M806708200; PMID: 19047049
  • Ross JS, Sheehan CE, Williams SS, Malfetano JH, Szyfelbein WM, Kallakury BV. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas. Am J Clin Pathol 2001; 116:122 - 8; http://dx.doi.org/10.1309/KUK0-1M3D-LGNE-THXR; PMID: 11447742
  • Afify A, Purnell P, Nguyen L. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration and invasion. Exp Mol Pathol 2009; 86:95 - 100; http://dx.doi.org/10.1016/j.yexmp.2008.12.003; PMID: 19167378
  • Morimoto K, Robin E, Le Bousse-Kerdiles MC, Li Y, Clay D, Jasmin C, et al. CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood 1994; 83:657 - 62; PMID: 7507730
  • Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene 2010; 29:3748 - 57; http://dx.doi.org/10.1038/onc.2010.131; PMID: 20418917
  • Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999; 94:2102 - 11; PMID: 10477740
  • Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77:1080 - 6; PMID: 1995093
  • Miyoshi H, Ohki M, Nakagawa T, Honma Y. Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with A t(8;21) chromosome translocation. Leuk Res 1997; 21:45 - 50; http://dx.doi.org/10.1016/S0145-2126(96)00089-6; PMID: 9029185
  • Xu ZX, Ding T, Haridas V, Connolly F, Gutterman JU. Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts. PLoS One 2009; 4:e8532; http://dx.doi.org/10.1371/journal.pone.0008532; PMID: 20046832
  • Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene 2009; 28:3221 - 34; http://dx.doi.org/10.1038/onc.2009.183; PMID: 19561642

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.